Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKropz Plc Regulatory News (KRPZ)

Share Price Information for Kropz Plc (KRPZ)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.00 (0.00%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £20.59m
KRPZ Live PriceLast checked at - London Stock Exchange

Intraday Kropz Plc Share Chart

Long Term Incentive Plan Awards

18 Jan 2022 10:53

RNS Number : 8310Y
Kropz PLC
18 January 2022
 

18 January 2022

 

Kropz Plc

("Kropz" or the "Company")

 

Long Term Incentive Plan Awards

 

Kropz Plc (AIM: KRPZ), an emerging African phosphate developer, is pleased to announce that the Company has issued ordinary shares in the Company to key members of the executive management team, including certain Persons Discharging Managerial Responsibilities ("PDMRs"), including Chief Executive Officer Mark Summers and Chief Operating Officer Michelle Lawrence. The issue of ordinary shares are due to awards vesting and issued under its Long Term Incentive Plan ("LTIP Awards"), issued on 31 July 2020 as announced on 4 August 2020.

 

These LTIP Awards had performance conditions aligned to the implementing the Company's strategic plans, including completion of the construction of the Elandsfontein mine within budget, on schedule and commissioning the plant before 31 December 2021 and updating of the Hinda feasibility study by 31 December 2021. The remuneration committee has confirmed that these performance conditions had been met.

 

As a result, it was agreed that a total of 6,700,000 ordinary shares in the capital of the Company would be issued at an exercise price of £0.001 an ordinary share. This includes issues to PDMRs as follows:-

 

 

Optionholders

Number of ordinary shares

Total exercise price

Mark Summers

2,350,000

£2,350

Michelle Lawrence

2,350,000

£2,350

 

 

Following the issue of the ordinary shares, Mark Summers and Michelle Lawrence will hold the following number of ordinary shares and ESOP and LTIP Awards:

Holder

Ordinary Shares

ESOP and LTIP Awards

No.

%

 

Mark Summers

2,764,889

0.30

5,762,609

Michelle Lawrence

2,350,000

0.26

3,865,137

 

Admission and Total Voting Rights

 

Application will be made for the 6,700,000 new ordinary shares to admission to trading on the AIM Market of the London Stock Exchange ("AIM"). It is expected that admission will become effective and that dealings in the new ordinary shares will commence at 8.00 a.m. on 24 January 2022 ("Admission").

 

On Admission, the Company's issued share capital on AIM will consist of 916,271,975 ordinary shares with voting rights. There are no shares held in treasury. This figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change of their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Further details of the PDMR dealings are included below. This information has been provided in accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018.

 

For further information visit www.kropz.com or contact:

 

 

Kropz Plc

 

 

Mark Summers (CEO)

+27 (0)79 744 8708

 

 

Grant Thornton UK LLP

Nominated Adviser

Samantha Harrison

Harrison Clarke

George Grainger

+44 (0) 20 7383 5100

 

 

Hannam & Partners

Broker

Andrew Chubb

Ernest Bell

+44 (0)20 7907 8500

 

 

Tavistock

Financial PR & IR (UK)

Nick Elwes

Jos Simson

Oliver Lamb

 

+44 (0) 207 920 3150

kropz@tavistock.co.uk

 

 

R&A Strategic Communications

PR (South Africa)

James Duncan

+27 (0) 11 880 3924

james@rasc.co.za 

 

 

About

 

Kropz is an emerging African explorer and developer of plant nutrient feed minerals with phosphate projects in South Africa and the Republic of Congo. The vision of the Group is to become a leading independent phosphate rock producer and to develop into an integrated, mine-to-market plant nutrient company focusing on sub-Saharan Africa.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ANNEX - PDMR notifications

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Mark Summers

2

 

Reason for the notification

 

a)

Position/status

 

Chief Executive Officer

b)

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Kropz plc

b)

LEI

 

2138005Y467BCQ3QOT77

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

 

 

Identification code

GB00BZ1HLP69

 

 

b)

 

Nature of the transaction

 

Exercise of options

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£0.001

2,350,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

18 January 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name

 

Michelle Lawrence

2

 

Reason for the notification

 

a)

 

Position/status

 

Chief Operating Officer

b)

 

Initial notification /Amendment

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Kropz plc

b)

 

LEI

 

2138005Y467BCQ3QOT77

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares

 

 

Identification code

GB00BZ1HLP69

 

 

b)

 

Nature of the transaction

 

Exercise of options

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£0.001

2,350,000

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A

 

 

- Price

 

 

 

e)

 

Date of the transaction

 

18 January 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBPMMTMTIBBIT
Date   Source Headline
29th May 20267:00 amRNSTotal Voting Rights
11th May 202610:27 amRNSDrawdown on Bridge Loan Facilities
30th Apr 202612:42 pmRNSECA Approval and Admission Date of Shares
20th Apr 20268:44 amRNSOperational Update
9th Mar 202611:49 amRNSDrawdown on Bridge Loan Facilities
25th Feb 20267:00 amRNSResults of WRAP Offer and Update on Subscription
20th Feb 20264:31 pmRNSWRAP Retail Offer for up to £91,077
20th Feb 20264:30 pmRNSFundraising, Amendment to Loan Terms & Update
26th Jan 202612:56 pmRNSDrawdown on Bridge Loan Facilities
18th Dec 20257:00 amRNSUnaudited Results for Six Months end 30 Sept 2025
17th Dec 20257:00 amRNSLegal Claim Update
9th Dec 20251:08 pmRNSDrawdown on Bridge Loan Facilities
8th Dec 20257:00 amRNSLoan Facility and Related Party Transaction
24th Nov 20257:00 amRNSTrading Update
6th Nov 20251:31 pmRNSResults of General Meeting
31st Oct 20252:41 pmRNSDrawdown on Bridge Loan Facilities
30th Sep 20255:08 pmRNSNotice of GM
29th Sep 20251:49 pmRNSResult of AGM
26th Sep 20254:16 pmRNSFinal Audited Results
4th Sep 20251:08 pmRNSNotice of AGM
27th Aug 202510:10 amRNSDrawdown on Bridge Loan Facilities
13th Aug 202511:21 amRNSDrawdown on Bridge Loan Facilities
30th Jul 20254:31 pmRNSDirector Disclosure Update
22nd Jul 20253:02 pmRNSLegal Claim Update
16th Jul 20251:08 pmRNSDrawdown on Bridge Loan Facilities
14th Jul 20255:04 pmRNSTrading Update and Loan Facility
30th May 20251:24 pmRNSDrawdown on Bridge Loan Facilities
28th May 20253:59 pmRNSFormal Execution of Loan Facility
21st May 20254:55 pmRNSTrading Update and Loan Facility
19th Mar 20257:23 amRNSNotice of Motion application by WWF SA
26th Feb 20257:00 amRNSTrading Update and Notification of Legal Claim
19th Dec 20247:00 amRNSUnaudited Results for Six Months end 30 Sept 2024
6th Nov 20242:00 pmRNSPassing of Lord Renwick of Clifton
4th Nov 20242:08 pmRNSResults of General Meeting
31st Oct 20247:00 amRNSTotal Voting Rights
17th Oct 20247:00 amRNSAdmission of Shares and Total Voting Rights
10th Oct 20244:30 pmRNSReceipt of Exchange Control Approval
30th Sep 20246:03 pmRNSFinal Audited Results
27th Sep 20241:05 pmRNSResult of AGM
20th Sep 202412:57 pmRNSResults of General Meeting
10th Sep 20247:00 amRNSResult of REX Retail Offer, Update on Subscription
3rd Sep 20247:01 amRNSRetail offer to raise up to £1.8 million
3rd Sep 20247:00 amRNSRestructuring, Fundraising, Notice of GM
27th Aug 20247:00 amRNSDrawdown on Bridge Loan Facilities
11th Jul 20247:00 amRNSTrading Update and further loan facility
20th Jun 20247:52 amRNSUpdate Mineral Resource Estimate - Elandsfontein
10th Jun 202411:05 amRNSStatement regarding share price movement
3rd Apr 20244:22 pmRNSDrawdown on Bridge Loan and BNP Loan Update
28th Mar 202412:11 pmRNSDrawdown on Bridge Loan Facilities
28th Mar 20248:22 amRNSUnaudited Results for 12 Months ended 31 Dec 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.